Comparison · Pregnancy Smart
Migraine medications during pregnancy
How do the options compare?
The comparison below weighs mainstream OB guideline standing, the depth of the pregnancy evidence base, dosing clarity, expected onset, and interactions worth flagging to your provider.
| Option | Studied pregnancy dose | Guideline support | Notes |
|---|---|---|---|
| Acetaminophen | Lowest effective dose; under 4,000 mg total in 24 hours for adults per FDA | ACOG names it the over-the-counter option for all headache types in pregnancy | The deepest pregnancy evidence base of any option here. Watch for acetaminophen hidden in other products so you do not double up. |
| Acetaminophen with caffeine | Total caffeine from all sources under 200 mg a day | ACOG notes this combination has been shown to help with migraine pain | Coffee, tea, and soda all count toward the same 200 mg. Two Excedrin tablets alone carry about 130 mg of caffeine. |
| Ibuprofen or naproxen (NSAIDs) | Second trimester only, 48 hours or less at a time per ACOG | FDA advises avoiding NSAIDs at 20 weeks or later and after 30 weeks entirely | Concerns are fetal kidney effects with low amniotic fluid, and early closure of the ductus arteriosus later on. |
| Sumatriptan and other triptans | As prescribed; not a first step | Prescription; largest pregnancy dataset among migraine-specific drugs | No increased chance of birth defects or miscarriage found. One cohort tied later use to atonic uterus and blood loss over 500 mL during labor. |
| Metoclopramide | As prescribed, by pill or IV; may be paired with diphenhydramine | ACOG names it for headaches that are new in pregnancy, daily, and constant | A prescription route worth asking about when over-the-counter options are not holding. |
| Aspirin-containing combinations (for example Excedrin Migraine) | Not a routine option in pregnancy | FDA includes aspirin in the 20-week NSAID advisory; the 81 mg exception is separate | Regular strength aspirin late in pregnancy is linked to early ductus arteriosus closure and to bleeding around delivery. |
| Butalbital combinations (for example Fioricet) | Not a routine option in pregnancy | No mainstream obstetric guideline positions it as a first or second choice | A large birth defects study linked use around conception to three heart defects, and butalbital crosses the placenta. |
- ACOG names two over-the-counter options for headaches in pregnancy: acetaminophen for all headache types, and NSAIDs for migraine pain that acetaminophen has not helped, second trimester only and 48 hours or less at a time. 1
- Acetaminophen tablets containing caffeine have been shown to help with migraine pain, provided total caffeine from every source stays under 200 mg a day, and prescription metoclopramide is an option for new daily headaches in pregnancy. 1
- FDA recommends avoiding NSAIDs at 20 weeks of pregnancy or later, limiting any use between 20 and 30 weeks to the lowest effective dose for the shortest duration, and avoiding them after 30 weeks, with low-dose 81 mg aspirin the one carve-out. 2
- Studies have not found an increased chance of birth defects or miscarriage with sumatriptan in pregnancy, and a US cohort of 767,994 pregnancies found no statistically significant association between triptan exposure and prematurity, low birth weight, major congenital malformations, or spontaneous abortion after adjusting for maternal migraine. 3
- Among 8,373 controls and 21,090 infants with birth defects, butalbital use around conception carried statistically significant adjusted odds ratios for tetralogy of Fallot, pulmonary valve stenosis, and secundum-type atrial septal defect, though the authors note exposure was rare and some findings may be spurious. 4
Which option makes sense?
The options above differ in their evidence, limitations, and suitability. Inclusion in this comparison is not a recommendation. Please consult your healthcare provider before making a decision based on these findings.
Disclosure: Pregnancy Smart makes pregnancy supplements, though not in this category. This comparison is a plain description of the pregnancy evidence, not a sales page.
Frequently asked questions
What is the safest migraine medication during pregnancy?
Acetaminophen has the deepest pregnancy evidence base and is what ACOG names first, including acetaminophen with caffeine for migraine pain. Safest on paper is not always effective for you, which is why the next step is a conversation about your specific pattern.
Can I take Excedrin Migraine or Fioricet while pregnant?
Both sit at the bottom of this comparison. Excedrin Migraine carries regular strength aspirin, which falls under the FDA 20-week NSAID advisory. Fioricet carries butalbital, which one large study linked to specific heart defects. Neither is a routine pregnancy choice.
Are triptans like sumatriptan safe in pregnancy?
They have the largest dataset of any migraine-specific drug, with no increased chance of birth defects or miscarriage found. They are still not a first step. One large cohort tied later-pregnancy use to atonic uterus and heavier blood loss during labor.
When is a headache in pregnancy an emergency?
A bad headache that will not go away, especially with swelling of the face or hands, vision changes, upper abdominal or shoulder pain, or sudden weight gain, needs an immediate call. A thunderclap headache that hits fast and hard is an emergency room visit.
Related in the library
Is it safe?
Is ibuprofen safe during pregnancy?
Is it safe?
Is caffeine safe during pregnancy?
Symptoms
Headaches during pregnancy
Is it safe?
Is sumatriptan safe during pregnancy?
Is it safe?
Is Excedrin migraine safe during pregnancy?
Comparisons
Deli meat alternatives during pregnancy
Comparisons
Raw egg alternatives during pregnancy
References
ACOG · https://www.acog.org/womens-health/faqs/headaches-and-pregnancy
FDA · https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic
Anti-migraine medications safety during pregnancy in the US
PubMed · https://pubmed.ncbi.nlm.nih.gov/39741626/
Maternal butalbital use and selected defects in the national birth defects prevention study
PubMed · https://pubmed.ncbi.nlm.nih.gov/24001268/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
